Peter David Suzdak

Directeur/Membre du Conseil chez Acidophil LLC

Profil

Peter David Suzdak founded Cardioxyl Pharmaceuticals LLC in 2006, where he worked as President & Chief Executive Officer.
Dr. Suzdak also founded Artesian Therapeutics, Inc., where he worked as President & Chief Executive Officer.
Dr. Suzdak also currently works at Acidophil LLC, as Director.
Dr. Suzdak also formerly worked at Rexahn Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2013 to 2018, Incara Pharmaceuticals Corp., as Director, Novo Nordisk A, as Director-Neurobiology Research in 1995, Aeolus Pharmaceuticals, Inc., as Independent Director from 2011 to 2013, Guilford Pharmaceuticals, Inc., as Senior Vice President-Research & Development in 2002, National Institute of Mental Health, as Associate-Pharmacology Research in 1988, and Corridor Pharmaceuticals, Inc., as Chief Scientific Officer.
Dr. Suzdak received his undergraduate degree from St. John's University and doctorate degree from the University of Connecticut.

Postes actifs de Peter David Suzdak

Sociétés	Poste	Début
Acidophil LLC	Directeur/Membre du Conseil	-

Anciens postes connus de Peter David Suzdak

Sociétés	Poste	Fin
REXAHN PHARMACEUTICALS, INC.	Directeur Général	14/11/2018
AEOLUS PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	08/05/2013
Incara Pharmaceuticals Corp.	Directeur/Membre du Conseil	09/08/2004
Guilford Pharmaceuticals, Inc.	Directeur Technique/Scientifique/R&D	01/01/2002
NOVO NORDISK A/S	Directeur Technique/Scientifique/R&D	01/01/1995